IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology



Similar documents
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

BRAF in the diagnostic evaluation of thyroid nodules

Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid

Craig Hallum Conference Investor Presentation

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15

Classificazioni citologiche: verso uno schema internazionale unificato?

Writing Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA

16.30 Kaposi s Sarcoma (KS): an interesting model for studying clinico-pathological relationship in tumorigenesis events

Resolving Cancer Heterogeneity:

European Federation of Cytology Societies 4th Annual Tutorial in Cytopathology Trieste, Italy Monday 6th to Friday 10th June 2011

Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid

International symposium on: The Impact of Genomic Deep Sequencing on

Title: Detection of erbb2 copy number variations in plasma of patients with esophageal carcinoma.

Molecular Pathogenesis of Thyroid Cancer

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France September 2008

Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases

LEGENDA. -23 th, 2015 EuROPEAN CONGRESS Of CYtOLOGY. MILAN, SEPtEMbER 20. Preliminary Program at a Glance 20 th September.

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Interferon Fundamentals 2014

D. N. Poller and S. Glaysher

BIOCHIP DEVELOPMENT FOR CANCER DIAGNOSIS Paradigmatic model of integration between knowledge and methodology

The following information is only meant for people who have been diagnosed with advanced non-small cell

Florence November 6-7, International Meeting of Computer Aided Implantology Academy PROGRAM. X Annual Meeting

Gruppi di lavoro Biologia Cellulare e Molecolare Biotecnologie e Differenziamento. Università degli Studi di Napoli Federico II BIOGEM.

Course Structure 2015/2016

The Diagnosis of Cancer in the Pathology Laboratory

Breast Pathology Masterclass 2016

Alì Giuseppe Dept of Physics, University of Calabria, Rende (CS), Italy.

Molecular Markers in Fine Needle Aspirates of the Thyroid

Mediterranean School of Oncology

Molecular Diagnostics in Thyroid Cancer

National Workshop of Hematology The TP53 Workshop

Worldwide Collaborations in Molecular Profiling

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

Kevin H. Hsu, MS, DO, Corrado Minimo MD, Seth Zwillenberg, MD

National Workshop of Hematology The TP53 Workshop

GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE

MOLECULAR REFLEX TESTING OF THYROID FNA

PRELIMINARY PROGRAMME I ACT. Bologna, 30 th November - 1 st December. Aula Chiantore

UNIVERSITÀ DEGLI STUDI DI BARI ALDO MORO, ITALY OFFICIAL ANNOUNCEMENT CALL FOR APPLICATION

KNOWLEDGE MANAGEMENT TRACKS

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?

Thyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD

Breast cancer research and a changing treatment pathway

New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel

Clinical Use of Molecular in the Treatment of Lung Cancer

Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)

targeted therapy a guide for the patient

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom

How To Become A Professor In Italy

Curriculum Vitae. Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian

Departamento de Economía Universidad Carlos III Tel Calle Madrid 126 Fax

Surgical Perspective of T1799A BRAF Mutation Diagnostic Value in Papillary Thyroid Carcinoma

BEYOND THE SLIDES st UDINE ECMO WORKSHOP

Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010

Interdisciplinary courses. Courses lecturers Schedule/lecturer. Prof. Maurizio Consoli (INFN) Prof. Mauro Dorato (University Roma Tre)

BREAST CANCER IN YOUNG WOMEN. OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano

Roche Diagnostics Driving Personalized Healthcare

Magic-5. Medical Applications in a GRID Infrastructure Connection. Ivan De Mitri* on behalf of MAGIC-5 collaboration

150 th Course Geriatrics, Molecular and Clinical Oncology: an Overwiew

Targeted Therapies in Lung Cancer

PRELIMINARY PROGRAMME I ACT. Bologna, 30 th November - 1 st December. Aula Chiantore

Supplementary Table 1. ILTE centers, patients, and PCR assays*

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities

The Faculty of Engineering and Architecture of th e University of Enna Kore The Degree Course in Aerospace Engineering. in collaboration with

The cooperative enterprise between national taxation and the european market

From Objects to Agents

workshop The challenge of Bio-districts during the programming period

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Workshop: La Medicina Telematica per la disabilità è una realtà: chi, dove e quando. Esperienze di teledermatologia a Modena

SMART CITY CHALLENGES : PLANNING FOR SMART CITIES. DEALING WITH NEW URBAN CHALLENGES

Provincia di Foggia Comune di Foggia

Student Details. Student ID e Date of Birth 10/02/1989 Place of Birth INDIA Nationality Italian. Education. Turin. Berlin

Thyroid FNA Ancillary Studies. Douglas P. Clark, M.D. Zubair W. Baloch, M.D., Ph.D.

Transcription:

Napoli 4 dicembre 2015 Università Degli Studi di Napoli Federico II Dipartimento di Sanità Pubblica Meeting Director: Giancarlo Troncone Centro Congressi Federico II Via Partenope 36 80121 Napoli IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology

Napoli 4 dicembre 2015 Università Degli Studi di Napoli Federico II Dipartimento di Sanità Pubblica Meeting Director: Giancarlo Troncone Centro Congressi Federico II Via Partenope 36 80121 Napoli IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology Until recently, cytological samples were only tested by sequential single-gene mutational tests. Next generation sequencing, matched with multiplex capture of targeted gene regions and analysed by sophisticated bioinformatics tools, enables the simultaneous detection of multiple mutations in multiple genes. By the development of miniaturized technology and of benchtop sequencers it is not unlikely that NGS will soon be adopted for routine molecular diagnostics, including cytological samples. The IV MOLECULAR CYTOPATHOLOGY meeting addresses (1) the most relevant methodological and technical aspects of the NGS analysis workflow and the diverse platforms available; (2) the issues related to daily practice implementation, namely, the cytological sample requirement and the validation procedures; and (3) the opportunities that NGS offers in different fields of cytopathology, to increase mutation detection sensitivity in paucicellular smears and to extend the analysis to a larger number of gene regions.

IV Molecular Cytopathology Napoli 4 Dicembre Preliminary Programme h 9.30 Welcome: Gaetano Manfredi Rettore Università degli studi di Napoli Federico II Maria Triassi Direttore Dipartimento Sanità Pubblica Gaetano de Rosa Presidente SIAPEC Ambrogio Fassina (Padova) Cytology Working group SIAPEC h 10.00 Meeting overview: Giancarlo Troncone (Napoli). Next Generation Cytopathology I Session : h 10.20 11.30 Update on Molecular cytopathology Chairmen: Pio Zeppa (Salerno) Philippe Vielh (Paris) Molecular cytopathology as a diagnostic tool Fernando Schmitt (Luxemburg) Molecular cytopathology as a predictive tool Spasineha Savic (Basel) FISH role in molecular cytopathology II Session: h 12,00 13.10 NGS analysis on cytology Chairmen: Antonio Marchetti (Chieti) Umberto Malapelle (Napoli) How to make NGS working on cytology Salto Tellez Manuel (Belfast) How to validate next generation sequencing Gabriella Fontanini (Pisa) Multitarget assay on cytology: not only NGS.

III Session : h 13,10 14.00 Liquid Biopsy Chairmen: Gabriella Fontanini (Pisa) Miguel Angel Molina (Barcellona ) EGFR mutations in circulating tumour DNA Antonio Marchetti (Chieti) Quantification of EGFR mutations in plasma samples of NSCLC patients: clinical implications Lunch (h 14.00 15.00) IV Session: Thyroid Molecular Cytopathology (15.00 16,10) Chairmen: Bernardette Biondi (Napoli) Fadda Guido (Roma) Italian consensus on Thyroid cytology and molecular testing Anna Crescenzi (Roma) Thyroid core needle biopsy: taking stock of the situation. Giovanni Tallini (Bologna) Molecular diagnosis of carcinomas of the thyroid gland. Rossi Ester Diana (Roma) Cytological changes and BRAF mutations V Session: Multigene Thyroid Cytopathology (16,30 17,40) Chairmen: Domenico Salvatore (Napoli) Eszlinger Markus (Leipizg) Development of molecular assay on thyroid routine smears Dario de Biase (Bologna) High sensitive BRAF assay on Thyroid cytology Claudio Bellevicine (Napoli) How NGS can refine the risk of malignancy of Indeterminate thyroid FNA Fulvio Basolo (Pisa) Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules Take home message: h. 17.40 18.00

Giancarlo Troncone (Napoli)